RecallHawk

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

ANI PHARMS

Summary

FDA approved BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE by ANI PHARMS. ANDA (Generic) approval (Manufacturing (CMC)) on 2023-12-06. TABLET, ORAL.

Details

Source

Drug Approval

External ID

ANDA076342-8

Action Date

2023-12-06

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, TABLET, ORAL. Application: ANDA076342

Company

Context & Analysis

ANI PHARMS has 27 FDA actions in our database.

Frequently Asked Questions

How often does ANI PHARMS have FDA actions?

ANI PHARMS has 27 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA076342-8" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions